Share-based Payment Arrangement, Expense of PALVELLA THERAPEUTICS, INC. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PALVELLA THERAPEUTICS, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • PALVELLA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1,790,000, a 799% increase year-over-year.
  • PALVELLA THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $4,585,000.
  • PALVELLA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $830,000, a 38% increase from 2023.
  • PALVELLA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $603,000, a 86% decline from 2022.
  • PALVELLA THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $4,402,000, a 16% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PALVELLA THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,585,000 $1,790,000 +$1,591,000 +799% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $2,994,000 $1,433,000 +$1,216,000 +560% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,778,000 $1,094,000 +$948,000 +649% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $830,000 $268,000 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $199,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $217,000 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $146,000 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2017 $3,046,000 $1,083,981 +$605,322 +126% 01 Oct 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 $2,440,678 $649,948 +$203,835 +46% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 $2,236,843 $559,878 -$51,967 -8.5% 01 Apr 2017 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 $2,288,810 $752,193 +$383,810 +104% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 $1,905,000 $478,659 +$137,189 +40% 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 $1,767,811 $446,113 +$108,324 +32% 01 Jul 2016 30 Sep 2016 10-Q 13 Nov 2017 2017 Q3
Q2 2016 $1,659,487 $611,845 +$343,806 +128% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017 2017 Q2
Q1 2016 $1,315,681 $368,383 +$151,048 +70% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $1,164,633 $341,470 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
Q3 2015 $337,789 01 Jul 2015 30 Sep 2015 10-Q 10 Nov 2016 2016 Q3
Q2 2015 $268,039 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016 2016 Q2
Q1 2015 $217,335 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1

PALVELLA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $830,000 +$227,000 +38% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $603,000 -$3,799,000 -86% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $4,402,000 -$813,000 -16% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $5,215,000 +$125,000 +2.5% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $5,090,000 -$284,000 -5.3% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2022 2021 FY
2019 $5,374,000 +$431,000 +8.7% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2018 $4,943,000 +$1,897,000 +62% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
2017 $3,046,000 +$1,141,000 +60% 01 Jan 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
2016 $1,905,000 +$740,367 +64% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
2015 $1,164,633 +$593,251 +104% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $571,382 01 Jan 2014 31 Dec 2014 10-K 23 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.